Literature DB >> 22734715

Cross-seeding effects of amyloid β-protein and α-synuclein.

Kenjiro Ono1, Ryoichi Takahashi, Tokuhei Ikeda, Masahito Yamada.   

Abstract

Amyloid β-protein (Aβ) and α-synuclein (αS) are the primary components of amyloid plaques and Lewy bodies (LBs), respectively. Previous in vitro and in vivo studies have suggested that interactions between Aβ and αS are involved in the pathogenesis of Alzheimer's disease and LB diseases. However, the seeding effects of their aggregates on their aggregation pathways are not completely clear. To investigate the cross-seeding effects of Aβ and αS, we examined how sonicated fibrils or cross-linked oligomers of Aβ40, Aβ42, and αS affected their aggregation pathways using thioflavin T(S) assay and electron microscopy. Fibrils and oligomers of Aβ40, Aβ42, and αS acted as seeds, and affected the aggregation pathways within and among species. The seeding effects of αS fibrils were higher than those of Aβ40 and Aβ42 fibrils in the Aβ40 and Aβ42 aggregation pathways, respectively. We showed that Aβ and αS acted as seeds and affected each other's aggregation pathways in vitro, which may contribute to our understanding of the molecular mechanisms of interactions between Alzheimer's disease and LB diseases pathologies.
© 2012 The Authors. Journal of Neurochemistry © 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734715     DOI: 10.1111/j.1471-4159.2012.07847.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  80 in total

1.  The Yeast Prion [SWI(+)] Abolishes Multicellular Growth by Triggering Conformational Changes of Multiple Regulators Required for Flocculin Gene Expression.

Authors:  Zhiqiang Du; Ying Zhang; Liming Li
Journal:  Cell Rep       Date:  2015-12-17       Impact factor: 9.423

2.  Co-chaperoning by amyloid-forming proteins: cystatins vs. crystallins.

Authors:  Eva Žerovnik
Journal:  Eur Biophys J       Date:  2017-05-06       Impact factor: 1.733

3.  Cross-seeding between Aβ40 and Aβ42 in Alzheimer's disease.

Authors:  Joyce Tran; Dennis Chang; Frederick Hsu; Hongsu Wang; Zhefeng Guo
Journal:  FEBS Lett       Date:  2016-12-29       Impact factor: 4.124

4.  Dopamine-induced α-synuclein oligomers show self- and cross-propagation properties.

Authors:  Matthew S Planchard; Sarah E Exley; Sarah E Morgan; Vijayaraghavan Rangachari
Journal:  Protein Sci       Date:  2014-08-01       Impact factor: 6.725

Review 5.  Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases.

Authors:  Anna Villar-Piqué; Matthias Schmitz; Niccolò Candelise; Salvador Ventura; Franc Llorens; Inga Zerr
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

Review 6.  Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis.

Authors:  Jinghui Luo; Sebastian K T S Wärmländer; Astrid Gräslund; Jan Pieter Abrahams
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

7.  Commentary: alpha-synuclein interacts with SOD1 and promotes its oligomerization.

Authors:  Anika M Helferich; Pamela J McLean; Jochen H Weishaupt; Karin M Danzer
Journal:  J Neurol Neuromedicine       Date:  2016

8.  Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM.

Authors:  Kun Zhao; Yeh-Jun Lim; Zhenying Liu; Houfang Long; Yunpeng Sun; Jin-Jian Hu; Chunyu Zhao; Youqi Tao; Xing Zhang; Dan Li; Yan-Mei Li; Cong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-31       Impact factor: 11.205

Review 9.  A brief overview of the Swi1 prion-[SWI+].

Authors:  Dustin K Goncharoff; Zhiqiang Du; Liming Li
Journal:  FEMS Yeast Res       Date:  2018-09-01       Impact factor: 2.796

10.  Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.

Authors:  Douglas G Walker; Lih-Fen Lue; Charles H Adler; Holly A Shill; John N Caviness; Marwan N Sabbagh; Haruhiko Akiyama; Geidy E Serrano; Lucia I Sue; Thomas G Beach
Journal:  Exp Neurol       Date:  2012-11-28       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.